Evonik has released its third-quarter 2023 financial results. The company has increased its adjusted EBITDA by 8% to €485 million in the third-quarter 2023 versus the second quarter. Reportedly due to persistently weak demand, the adjusted EBITDA fell by 21% year-on-year.
“The economic recovery is still a long time coming,” said Christian Kullmann, chairman of Evonik’s management board. “That is why we are focusing on the levers at our disposal. And that is increasingly having an effect.”